Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
Pathophys of asthma - General
|
Genetic component and environmental exposures
SM contraction leading to significant airway narrowing. Massive inflammation in mucosa/submucosa leading to mucus plugging of narrow airways. |
|
TH1 or 2 more common in asthmatics?
|
They tend to do a TH2 response.
Mast cells are also important. |
|
Which mediator probably causes muscle spasm?
|
Histamine
|
|
Which mediators probably initially cause inflammatory exudate in the submucosa?
|
Leukotrienes, thromboxanes, PGs
Inflammation and mucus then contributes to occlusion of the lumen. |
|
One thing to definnitely ask about in dx asthma
|
Nocturnal sx
|
|
Asthma vs. COPD
|
Asthma - Reversible bronchial SM contraction, epithelial edema.
COPD - Hypertrophied submucosal bronchial glands much more than asthma, increased risk of infection. |
|
Big diff in short acting and long acting beta2 agonists
|
Short - Short duration of action but quick onset. (acute crisis)
Long - longer duration of action and slower onset (chronic use) |
|
Beta 2 receptor
|
Linked to adenyl cyclase to increase cAMP and this brings down intracellular calcium to mediate bronchodilatation.
Enhances mucociliary clearance Decreases microvascular permeability Suppresses mediator release from inflammatory cells. |
|
Main benefits of inhaled
|
Less dose so less systemic toxicity
Quicker onset of action. |
|
Beta2 agonist metabolism
|
COMT/MAO
|
|
Why does tolerance/tachyphylaxis develop with beta2 agonists?
|
With constant receptor stimulation, arrestin protein signals internalization of the beta2 receptor.
|
|
AEs of beta2 agonists
|
Tachycardia, palpitations, flushing, exacerbation of angina/arrythmias, vasodilation of pulmonary artery leading to perfusion of non-ventilated areas (V/Q mismatch)
Tremor/anxiety (beta2 affects on muscle), headache, insomnia Hypokalemia, hyperglycemia (normal beta2 response). |
|
Beta2 agonists used for...
|
i think asthma and COPD
|
|
Strucutre of long-acting beta2 agonists
|
Longer side chains and two rings.
|
|
Always rx long acting beta 2 agonists with...
|
steroids to reduce risk of inflammation and hypocia causing death.
|
|
Two long-acting beta2 agonists
|
salmeterol and formoterol.
|
|
Short acting beta2 agonist
|
Albuterol
But there is also metaproterenol, bitolterol, pirbuterol, terbutaline, fenoterol. ("you dont have to memorize all these") |
|
Anticholinergics (3)
|
ipratropium
oxitropium tiotropium (long-acting/once a day) these allow SM to dilate. |
|
Anticholinergics vs. beta-agonists
|
Slower onset of action and less bronchodilation.
|
|
Anticholinergic SEs
|
Anticholinergic effects only at high doses.
Bitter taste (this is the main one) Paradoxical bronchoconstriction due to a preservative that some pts are sensitive to. Drying of secretions in the lungs DOES NOT OCCUR! |
|
Methyl Xanthine drug
|
theophylline
|
|
Theophylline mechanism of action
|
Inhibition of phosphodiesterase (normally breaks down cAMP)
Block the inhibition that adenosine produces of adenylate cyclase IT BASICALLY INCREASES cAMP!!! |
|
Pharmacodynamics of methyl xanthines (theophylline)
|
Relax SM (vasodilate and bronchodilation)
Increased CNS and CV stimulation. Less skeletal muscle fatigue Diuresis |
|
Main toxicity issues with theophylline
|
N/V
CV at relatively high doses or CNS toxicity at very high doses. Has lots of drug interactions |
|
All the drugs in this lecture can be used for...
|
Asthma/COPD
|
|
Drugs that are cromokalim derivatives
|
Sodium cromoglycate
Nedocromil They prevent mast cell degran. |
|
Inhaled steroids
|
Beclomethasone
Fluticasone |
|
Systemic steroids
|
Hydrocortisone
Prednisone Prednisolone Methylprednisolone |
|
Uses of sodium cromoglycate
|
Proph. in antigenic and exercise induced asthma.
Also good in allergic rhinitis and conjunctivitis. VERY GOOD TO TAKE THIS BEFORE EXERCISE. |
|
Mechanism of sodium cromoglycate
|
Doesn't directly bronchodilate
Inhibits release of inflamm. mediators from mast cells Supresses effects of kinins of inflamm cells. Inhibits sensory C-fiber endings to reduce cough. |
|
SEs of cromoglycate
|
very rare
occasional coughing/wheezing/HA/nausea. They aren't used over steroids just because they are a little less effective. |
|
Use of systemic steroids (hydrocortisone and prednisone)
|
Acute and severe asthma (although it takes hours to work so it is used prophylactically)
|
|
Uses of inhaled steroids (beclomethasone and fluticazone)
|
Prophylaxis in mild/moderate asthma.
Can be combined with systemic steroids to reduce their dose (in chronic severe asthma) |
|
Mechanism of corticosteroids (systemic and inhaled)
|
Lipophilic, hits a receptor and goes to DNA and...
Prevents proinflammatory mediators and induces things that fight inflammation. |
|
Cells that steroids work on
|
lymphocytes, endothelial cells, monocytes, basophils.
|
|
Length of effect of steroids
|
Last way past drug life in body because so many processes are modulated.
|
|
Inhaled steroids - pharmacokinetics
|
Only 10% reaches bronchi.
Metab by CYP3A Low systemic concentrations. |
|
Inhaled steroids SEs
|
Local thrush and dysphonia
At high systemic doses you can get HPA-axis suppression, bruising, cataracts, inhibition of bone growth, behavioral disturbances (especially in kids) |
|
Steroids - relationship of anti-inf potency and mineralo potency
|
More anti-inf, less mineralo (where you will have less water retention and rise in blood glucose)
|
|
Acute SEs of systemic steroids
|
CNS, metabolic (hyperglycemia and salt/water retention), proximal myopathy, infection
|
|
Chronic SEs of systemic steroids
|
HPA axis suppression, cushing appearance, infection (opportunistic)
|